Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2019-03-01+192,500→ 192,500 totalExercise: $4.52Exp: 2029-03-01→ Common Stock (192,500 underlying)
Footnotes (1)
- [F1]3yr 33% On Vest beginning on 01-Mar-2019